NIH-funded research R21 grant

Investigating how lipid changes in brain cells relate to Alzheimer's disease

Official title: Uncovering Dementia-Related Lipid Alterations and Mechanisms in Astrocytes

Funded at Weill Medical Coll of Cornell Univ · NIH-10885573 · Data updated 2026-11-12

This study is looking at how fats in the brain might affect memory and thinking in people with Alzheimer's and similar conditions, hoping to find new ways to help improve their brain health and daily life.

More Dementia research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startMay 15, 2024
Project endApril 30, 2026
Funding year2024
Award (this year)$466,125
NIH project number1R21AG087400-01
Project IDNIH-10885573 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias, particularly those experiencing cognitive decline.

Less likely to help

Patients with non-degenerative forms of dementia or those without any cognitive impairment may not benefit from this research.

What this research studies

This research focuses on understanding the role of lipids in Alzheimer's disease and related dementias. It examines how changes in lipid metabolism within astrocytes, a type of brain cell, may affect neuronal health and function. By analyzing the molecular changes in lipids associated with dementia, the study aims to uncover potential therapeutic targets that could improve cognitive and behavioral outcomes for patients. The approach includes detailed investigations of lipid profiles and their interactions with neurons in the context of Alzheimer's pathology.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve cognitive function and slow the progression of Alzheimer's disease.

How similar studies have gone: Previous research has indicated that targeting lipid metabolism may have therapeutic potential in neurodegenerative diseases, suggesting a promising avenue for this investigation.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Orr, Anna Goldshmidt — Weill Medical Coll of Cornell Univ
  • Study coordinator: Orr, Anna Goldshmidt

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.